DEVICE CATEGORY · OPR
Intrasaccular Flow Disruption Device
An intrasaccular flow disruption device is intended for use to treat wide-neck intracranial aneurysms in the neurovasculature through an endovascular approach.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Microvention, Inc. | PMA supplement | Oct 27, 2026 | FDA | |
| Microvention, Inc. | PMA approval | Dec 31, 2018 | FDA |
Source information
Follow the FDA links to view the original records.

